Infectious Diarrhoea
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Cosmo PharmaceuticalsIreland - Dublin
1 program1
400 mg Rifamycin SV dosagePhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Cosmo Pharmaceuticals400 mg Rifamycin SV dosage
Clinical Trials (1)
Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea
Start: Feb 2008Est. completion: Jul 2008
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space